NOV 07, 2017 10:00 AM PST

WEBINAR: Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutions

Sponsored by: Miltenyi Biotec
Speaker
  • Translational R&D, Cell Biology, Lentigen Technology, Inc., a Miltenyi Biotec Company
    Biography
      Dr. Dina Schneider holds PhD in Pharmacology and Toxicology from Michigan State University. Her doctoral thesis focused on pathways of B cell activation and differentiation. Her post-doctoral work at the University of Michigan, Ann Arbor, focused on cellular immune responses to viral infections in airway inflammatory diseases. In 2011, Dr. Schneider transitioned to industry, where she contributed to numerous projects in synthetic immunology, immunotherapy, and chimeric antigen receptor (CAR) T cell-based therapy. Dr. Schneider leads the Cell Biology group at Lentigen Technology, Inc., a Miltenyi Biotec Company, in Gaithersburg, MD. Her group is focused on pre-clinical development of novel CAR-based therapies, and on the implementation of CliniMACS Prodigy® platform for preparation of cell-based therapeutics.

    Abstract

    DATE: November 7, 2017 
    TIME: 10:00AM PST

    Chimeric Antigen Receptor (CAR)-transduced T lymphocytes have demonstrated impressive clinical activity against B cell malignancies in phase I trials.  In most instances, lentivirus-based or a retrovirus-based gene vectors were used to introduce the therapeutic gene expression cassette into the genome of T lymphocytes.  The gene expression cassette is composed of an internal promoter and the CAR, created by splicing together of extracellular antigen-binding motifs, linker and transmembrane domains, and intracellular lymphocyte signaling domains.  This synthetic engineered receptor can be modified in a number of ways in order to further improve CAR T efficacy and safety.  We have found that the combination of two extracellular binding domains is possible, thus expanding the antigens targeted by a single CAR construct, and potentially providing a more effective barrier to the generation of antigen-escape variants. Making CAR-based immunotherapy broadly available to those in need, requires the ability to isolate, activate, transduce, and expand T cell or NK cell populations in a safe clinically-relevant platform.  The CliniMACS® Prodigy is a closed cell culture system that combines recent advances in lymphocyte isolation (using antibody-conjugated matrices), activation (using an anti-CD3/CD28 nanomatrix), and automated culture using optimized media and cytokines, into a single platform suitable for the introduction of therapeutic gene vectors, lymphocyte transduction, culture and expansion, and final formulation.  Using clinical-grade lentivirus-based gene vectors we have demonstrated the ability to produce CAR-expressing T cells.  The CliniMACS® Prodigy platform provides a standardized solution for broad application of CAR-based therapies in clinical studies.

     

    Learning Objectives:

    • Review critical aspects for creating CAR T cells
    • Review process of CAR-modified cell manufacturing

     


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 07, 2017 10:00 AM PST

    WEBINAR: Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutions

    Sponsored by: Miltenyi Biotec

    Specialty

    Cancer Research

    Immunology

    Biotechnology

    Molecular Biology

    Cell Biology

    Cancer Therapeutics

    Biomarkers

    Cell Culture

    Biochemistry

    Cancer Diagnostics

    Clinical Diagnostics

    Clinical Research

    Antibodies

    Molecular Diagnostics

    Laboratory Testing

    Geography

    North America66%

    Europe17%

    Asia9%

    South America4%

    Oceania1%

    Africa1%

    Registration Source

    Website Visitors100%

    Job Title

    Scientist14%

    Research Scientist14%

    Executive13%

    Student11%

    Facility/Department Manager9%

    Medical Doctor/Specialist8%

    Medical Laboratory Technician6%

    Educator/Faculty6%

    Post Doc4%

    Clinical Laboratory Scientist4%

    Lab Management4%

    Consultant2%

    QC/QA2%

    Marketing/Sales1%

    Chemist1%

    Biologist1%

    Organization

    Biotech Company12%

    Academic Institution9%

    Research Institute6%

    Clinical Laboratory5%

    Hospital5%

    Life Science Company3%

    Government3%

    Pharmaceutical Company2%

    Non-Profit Organization2%

    Medical Center2%

    Medical School2%

    Medical Device Company1%

    Ambulatory Care1%

    Consultant1%

    Other2%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more